title: MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
abstract: The anti-retrovirus cell-mediated immunity was repeatedly investigated in seven monkeys (Macaca sylvana). Four of these animals were injected with cell-free supernatants containing human immunodeficiency viruses: two monkeys received HIV1 Bru (2.5 x 10(6) cpm), two received HIV2 Rod (1.5 x 10(6) cpm). Two additional animals were injected with a cell-free supernatant containing simian immunodeficiency virus SIV/mac 251 (1.5 x 10(6) cpm) and the last animal served as control. The four macaques infected with HIV2 Rod and SIV/mac 251 seroconverted. Freshly isolated and non stimulated peripheral blood mononuclear cells from these infected macaques and from the uninfected control were repeatedly assessed for cytolytic activity. Target cells consisted of heterologous human cell lines expressing HIV1 Bru, HIV2 Rod or SIV/mac proteins. A significant cytotoxic activity, non-restricted at the major histocompatibility complex class I (MHC-I), was demonstrated in one HIV2 Rod-infected animal (F8) and in one SIV/mac 251-infected animal (M1). This last animal showed progressively diminishing cytolytic activity that was correlated with a pronounced decrease in CD4+ lymphocytes. An AIDS-like disease developed in M1, with presence of lymphadenopathy, weight loss, diarrhea and opportunistic infections. Cytotoxic activity was active against SIV and HIV2-infected target cells in an MHC-unrestricted manner; it was specific to virus-infected cells and there was cross-reactivity between HIV2 and SIV. Cytotoxic effectors appeared to be mainly CD8+ cells. This model may prove to be very useful in evaluating the capacity of candidate AIDS vaccines to elicit effective cell-mediated immune responses.
authors.affiliation: Laboratoire d'Immunovirologie, Institut Pasteur du Maroc, Casablanca.
authors.forename: B
authors.initials: B
authors.lastname: Charaf
authors.forename: K
authors.initials: K
authors.lastname: Sanhadji
authors.forename: S
authors.initials: S
authors.lastname: Sekkat
authors.forename: B
authors.initials: B
authors.lastname: Farouqui
authors.forename: J L
authors.initials: JL
authors.lastname: Touraine
authors.forename: A
authors.initials: A
authors.lastname: Benslimane
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000818:Animals; D015496:CD4-Positive T-Lymphocytes; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D004195:Disease Models, Animal; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000472:pathogenicity; D015498:HIV-2 / Q000472:pathogenicity; D006801:Humans; D007111:Immunity, Cellular; D007958:Leukocyte Count; D008251:Macaca / Q000276:immunology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000472:pathogenicity; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology